For years, a quiet tension has existed between the rapid adoption of virtual care and the anxiety of policymakers. While the convenience of seeing a doctor via a screen is undeniable, critics have long feared that removing the physical barriers to healthcare would open a floodgate of unnecessary visits, ultimately driving the cost of medical care even higher.
However, new evidence suggests that this fear may have been unfounded. Research led by the David Geffen School of Medicine at UCLA indicates that the expansion of telemedicine has not significantly increased medical visits or healthcare spending across various payer types. The findings, published in the peer-reviewed journal JAMA Network Open, provide a critical data point for a global healthcare landscape struggling to balance accessibility with fiscal sustainability.
This analysis arrives at a pivotal moment as governments and insurance providers evaluate the long-term viability of digital health. For patients, the shift toward virtual care has meant fewer commutes and easier access to specialists. For lawmakers, the primary concern has been whether this “frictionless” access would trigger a spike in utilization that the current economic infrastructure cannot support.
The study suggests that the actual impact of telemedicine on healthcare costs has remained stable, debunking the theory that virtual platforms act as a catalyst for over-utilization. By tracking spending patterns, researchers found that heavy users of telemedicine did not drive costs upward in a way that deviated significantly from the patterns seen in lighter users.
The Pandemic Pivot and CMS Policy Shifts
The current state of virtual care is largely a result of the emergency measures implemented during the COVID-19 pandemic. In 2020, the Centers for Medicare & Medicaid Services (CMS) introduced several key policy flexibilities to ensure continuity of care when in-person visits were impossible. These changes were not merely technical; they were financial and structural shifts that fundamentally altered how providers were compensated.
Among the most significant changes were the introduction of payment parity—ensuring that providers were paid the same for a virtual visit as they were for an in-person one—and the waiving of strict geographic restrictions that previously limited where a patient had to be located to receive reimbursable care. CMS eliminated many out-of-pocket cost-sharing requirements for patients, effectively making virtual visits more affordable for the end-user.
These CMS flexibilities were designed as temporary measures, but their impact was profound. They allowed the healthcare system to stress-test the scalability of telemedicine on a national level. As the pandemic ended, lawmakers extended these policies to gather more data on how this expanded access influenced overall healthcare utilization and spending.
Debunking the Utilization Myth
The central question facing health economists has been whether the ease of telemedicine creates “induced demand”—the idea that people will seek medical attention for minor issues they would have otherwise ignored or managed at home if an in-person trip were required.
Dr. John N. Mafi, associate professor-in-residence of medicine in the division of general internal medicine and health services research at the David Geffen School of Medicine at UCLA, led the study. According to Dr. Mafi, the evidence suggests that the predictions of massive spending spikes did not materialize on a national scale.
“Our findings suggest neither prediction came true on a national scale,” Mafi stated, referring to both the hope that telemedicine would drastically increase reach for the underserved and the fear that it would drive up costs. He noted that as the use of telemedicine grew, the spending and visit patterns of heavy users tracked closely with those of lighter users, suggesting that virtual care often replaces an in-person visit rather than adding an entirely new, unnecessary encounter to the patient’s history.
This suggests that telemedicine is functioning more as a tool for efficiency and convenience than as a driver of medical inflation. When a patient can resolve a follow-up question or a routine prescription renewal via video, it reduces the burden on physical clinics without necessarily increasing the total volume of care required for that patient’s condition.
What This Means for the Future of Healthcare Access
The implications of this research extend beyond the balance sheet. If telemedicine does not inherently drive up costs, the argument for its permanent integration into the healthcare system becomes stronger. For populations in rural areas or those with mobility issues, the removal of geographic restrictions is not a luxury but a necessity for health equity.
However, the study also highlights a sobering reality: the wider availability of telemedicine has not yet fully realized the goal of reaching those without easy access to doctors on a national scale. While the technology exists and the cost concerns have been mitigated, the “digital divide”—inequalities in internet access and device ownership—remains a barrier that policy alone cannot solve.
For the medical community, the stability of spending patterns confirms that virtual care can be integrated into a hybrid model of medicine. The goal is not to replace the physical examination—which remains essential for diagnosis and complex treatment—but to optimize the patient journey by utilizing the most efficient medium for each specific interaction.
The 2027 Deadline: A Policy Crossroads
Despite the reassuring data regarding spending, the legal framework supporting the current telemedicine expansion is precarious. The CMS flexibilities introduced during the pandemic are not permanent; they are currently scheduled to expire in 2027.
As this deadline approaches, lawmakers are engaged in a heated debate over whether to permanently extend these policies or modify them. The UCLA-led research provides a timely rebuttal to the argument that permanent extensions would lead to unsustainable spending. If the data shows that utilization has remained stable despite the removal of barriers, the fiscal argument against permanent payment parity and geographic flexibility is significantly weakened.
The next few years will be critical. Policymakers must now decide if they will allow the system to revert to pre-pandemic restrictions—potentially disrupting millions of patient-provider relationships—or if they will codify these digital advancements into law.
The upcoming legislative sessions leading into 2027 will be the primary checkpoint for these decisions. Stakeholders, including patient advocacy groups and medical associations, are expected to use this data to lobby for the permanent adoption of virtual care flexibilities.
Do you believe virtual care has improved your access to health services, or do you prefer the traditional in-office experience? Share your thoughts in the comments below or share this article with your network to join the conversation on the future of healthcare.